why choose us

Clinical Trials Search

Showing 13,930 of 132,963 result(s)
Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer

Status: Completed

Condition: Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Interventions: Three doses of Sipuleucel-T, each containing a minimum of 50 million autologous CD54+ cells activated with PAP-GM-CSF, given at week 0, 2, and 12-14.

Date: 2023-03-28

Molar Incisor Hypomineralization and Hypomineralized Second Primary Molars

Status: Completed

Condition: Molar Incisor Hypomineralization

Interventions:

Date: 2023-03-28

Perceived Quality of Family Planning Counselling

Status: NOT_YET_RECRUITING

Condition: Contraception

Interventions:

Data will be collected through a semi-structured interview administered questionnaire which includes:

  1. Socio-demographic characteristics

    Date: 2023-03-28

A Novel Virtual Reality Task in Parkinson's Disease

Status: Completed

Condition: Parkinson Disease

Interventions: A virtual reality task where participants wear the Virtual Reality headset and respond to targets.

Date: 2023-03-28

Companion Dog Walking for ICU Survivor Health

Status: Completed

Condition: Post Intensive Care Syndrome

Interventions: Participants will be asked to walk their dog three times per week, for a minimum of 30 minutes each day of walking, over an 8-week period.

Date: 2023-03-28

Smart Lighting for Nursing Home Residents With Dementia

Status: Completed

Condition: Alzheimer's Disease and Related Dementias

Interventions: The Proposed Smart Ambient Bright Light (SABL) includes tunable LED lights, photosensors, and controllers.
The SABL will provide bright light tar

Date: 2023-03-28

Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses.

Status: COMPLETED

Condition: Myopia

Interventions: one week wear

Date: 2023-03-28

Study of INBRX-101 Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema

Status: Completed

Condition: Alpha 1-Antitrypsin Deficiency

Interventions: A1PI, Recombinant, Bivalent Fc Fusion Protein

Date: 2023-03-28

A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction

Status: Completed

Condition: Breast Cancer

Interventions: A starting dose of vericiguat 2.5 mg will be administered in-clinic at the Day 1 visit.
Titration visits will occur on Days 14 and 28, with dose

Date: 2023-03-28

Study of Avelle™ Negative Pressure Wound Therapy (NPWT) System

Status: NOT_YET_RECRUITING

Condition: Surgical Wound, Recent

Interventions: The study device combines a sterile dressing comprising gelling fibre technology to absorb wound exudate with negative pressure applied to the wound v

Date: 2023-03-28